Published in Cancer Weekly, August 12th, 2008
"Patients received pemetrexed 500 mgm-2 and carboplatin AUC 5mg ml(-1) min(-1) intravenously every 21 days with standard vitamin supplementation. Elderly patients were defined as those >= 70 years old. A total of 178 patients with an ECOG performance status of <= 2 were included. Median age was 65 years ( range 38-79), with 48 patients >= 70 years (27%). Grade 3-4...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.